A brief review of the current breast cancer prevention trials and proposals for future trials

European Journal of Cancer

Volumn 36, Issue 10, 2000, Pages 1298-1302

  Cuzick, J ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Breast cancer; Chemoprevention; Meta analysis; Raloxifene; Tamoxifen

Indexed keywords

ESTROGEN RECEPTOR; RALOXIFENE; TAMOXIFEN;

ADULT; BONE; BREAST CANCER; CANCER INCIDENCE; CANCER PREVENTION; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CLINICAL TRIALS; ENDOMETRIAL NEOPLASMS; FEMALE; HOT FLASHES; HUMANS; MENSTRUATION DISTURBANCES; META-ANALYSIS; MIDDLE AGED; RALOXIFENE; RISK FACTORS; TAMOXIFEN;

EID: 0034131080     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00106-4     Document Type: Conference Paper

References (19)

1. Cuzick J, Baum M. Tamoxifen and contralateral breast cancer. Lancet 1985, ii, 282.
2. Cuzick J, Wang DY, Bulbrook RD. The prevention of breast cancer. Lancet 1986, i, 83-86.
3. Fisher B, Costantino JP, Wickerham LD, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-l Study. J Natl Cancer Inst 1998, 90, 1371-1388.
4. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998, 351, 1451-1467.
5. Powles T, Eeles R, Ashley S, et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet 1998, 352, 98-101.
6. Veronesi U, Maisonneuve P, Costa A, et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Lancet 1998, 352, 93-97.
7. Cummings SR, Eckert S, Krueger KA, et al. The effect of raloxifene on risk of breast cancer in postmenopausal women. Results from the MORE randomized trial. JAMA 1999, 281, 2189-2197.
8. Cuzick J. Chemoprevention of breast cancer with tamoxifen. In Hakama M, Beral V, Buiatti E, Faivre J, Parkin DM, eds. Chemoprevention in Cancer Control. Lyon, IARC Scientific Publications No. 136, IARC, 1996, 95-109.
9. IARC. Some Pharmaceutical Drugs. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 66. Lyon, IARC, 1996, 253-365.
10. Han X, Liehr J. Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Res 1992, 52, 1360-1363.
11. Greaves P. Ten year carcinogenicity study of tamoxifen in Alderley Park Wister-derived rats. Cancer Res 1993, 53, 3919-3924.
12. Rutqvist LE, Johansson H, Signomklao T, et al. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. J Natl Cancer Inst 1995, 87, 645-651.
13. Powles TJ, Tillyer CR, Jones AL, et al. Prevention of breast cancer with tamoxifen - an update on the Royal Marsden Hospital pilot programme. Eur J Cancer 1996, 26, 680-684.
14. Day R, Ganz PA, Costantino JP, et al. Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-l Study. J Clin Oncol 1999, 17, 2659-2669.
15. Powles TJ, Hickish T, Kanis A, et al. Effect of tamoxifen on bone mineral density measured by dual-energy X-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol 1996, 14, 78-84.
16. Delmas PD, Bjarnason NH, Mitlak BC, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. New Engl J Med 1997, 337, 1641-1647.
17. Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. JAMA 1999, 282, 637-645.
18. McDonald CC, Stewart HJ, for the Scottish Breast Cancer Committee. Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. Br Med J 1991, 303, 435-437.
19. Rutqvist LE, Mattson A. Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomised trial of adjuvant tamoxifen. J Natl Cancer Inst 1993, 85, 1398-1406.